Close Menu

NEW YORK (GenomeWeb) – PerkinElmer announced after the close of the market on Thursday that its fourth quarter revenues rose 18 percent year over year.

For the three months ended Dec. 30, 2018, the company posted revenues of $756.3 million compared to $641.6 million a year ago. It beat the consensus Wall Street estimate of $746.6 million.

Core organic revenue growth was 7 percent, the company said.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Retraction Watch writes that a cancer researcher has had an eighth paper retracted.

Computational biologist James Taylor has died, according to Johns Hopkins University.

The Centers for Disease Control and Prevention is starting to test people for SARS-CoV-2 antibodies, according to the New York Times.

In PLOS this week: features of tumor-infiltrating immune cells, regulatory effects of SNPs associated with prostate cancer risk, and more.